About
Join us on November 4th 9h-13h at Institut Pasteur for a half-day symposium exploring how AI-driven design and high-throughput technologies are reshaping antibody discovery.
Four companies will showcase cutting-edge solutions for generating and selecting antibodies or fragments for diverse applications — from immunolabelling, crystallography, imaging, flow cytometry, to diagnostics and therapeutic development. As part of annual meetings dedicated to protein binder development, this first edition will highlight antibody innovation in one dynamic morning session.
For visitors, register by sending an email to thierry.rose@pasteur.fr
Location: Auditorium Agnès Ullmann, Institut Pasteur, Paris

Program:
9h00-9h15 Welcoming participants
9h15-9h20 Introduction. Muriel UHRING (SinoBiological)
9h20-9h50 Protein binder generation and selection: immunisation, random evolution/synthesis or AI – for what purposes? Thierry ROSE (Institut Pasteur, Paris)
9h50-10h25 Accelerating your research using advanced protein and antibody development platforms. Jing GONG (SinoBiological)
10h25-11h00 Synthetic nanobody selection and optimization: Phage and Yeast together for the better. Jean-Christophe RAIN (Hybrigenics)
11h00-11h30 Coffee break
11h30-12h05 AI meets evolution: Towards de novo binders ? Philippe HERMAN (ImmunoChem)
12h05-12h40 AI-assisted mAb generation and selection. Astrid MUSNIER (MAbSilico)
12h40-12h45 Conclusion. Pierre LAFAYE (Institut Pasteur, Paris)




